{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:36:29Z","timestamp":1792496189951,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6490,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1093\/annonc\/13.s1.44","type":"journal-article","created":{"date-parts":[[2012,1,20]],"date-time":"2012-01-20T05:08:54Z","timestamp":1327036134000},"page":"44-51","source":"Crossref","is-referenced-by-count":68,"special_numbering":"S1","title":["Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell\/histiocyte\u2010rich B cell lymphoma"],"prefix":"10.1016","volume":"13","author":[{"given":"T.","family":"R\u00fcdiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Gascoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Delabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"De Wolf Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Poppema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Xerri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gisselbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wiedenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.K.","family":"M\u00fcller\u2010Hermelink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/13.S1.44_bb0005","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00000478-198806000-00003","article-title":"T-cell-rich B-cell lymphoma","volume":"12","author":"Ramsay","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/13.S1.44_bb0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2559.1991.tb00024.x","article-title":"Large B-cell lymphoma rich in T-cells and simulating Hodgkin\u2019s disease","volume":"19","author":"Chittal","year":"1991","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/13.S1.44_bb0015","first-page":"37","article-title":"Histiocyte-rich B-cell lymphoma","volume":"16","author":"Delabie","year":"1992","journal-title":"A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin\u2019s disease, paragranuloma subtype. Am J Surg Pathol"},{"key":"10.1093\/annonc\/13.S1.44_bib0005","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","article-title":"World Health Organization Classification of Tumours","author":"Jaffe","year":"2001"},{"key":"10.1093\/annonc\/13.S1.44_bb0020","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin\u2019s disease and lymphocyte-rich classical Hodgkin\u2019s disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin\u2019s Disease","volume":"17","author":"Diehl","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/13.S1.44_bb0025","first-page":"1889","article-title":"European Task Force on Lymphoma Project on Lymphocyte Predominance Hodgkin\u2019s Disease: Histological and immunohistological analysis of submitted cases reveals two types of Hodgkin\u2019s disease with a nodular growth pattern and abundant lymphocytes","volume":"96","author":"Anagnostopoulos","year":"2000","journal-title":"Blood"},{"key":"10.1093\/annonc\/13.S1.44_bb0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199708143370703","article-title":"Origin of nodular lymphocyte-predominant Hodgkin\u2019s disease from a clonal expansion of highly mutated germinal-center B cells","volume":"337","author":"Marafioti","year":"1997","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"10.1093\/annonc\/13.S1.44_bb0035","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/annonc\/9.suppl_5.S31","article-title":"Workshop report on Hodgkin\u2019s disease and related diseases (\u2018grey zone\u2019 lymphoma)","volume":"9","author":"R\u00fcdiger","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/13.S1.44_bb0040","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood.V93.8.2679","article-title":"Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells","volume":"93","author":"Brauninger","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/13.S1.44_bb0045","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0002-9440(10)65742-2","article-title":"Pathological findings in human autoimmune lymphoproliferative syndrome","volume":"153","author":"Lim","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/13.S1.44_bb0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V98.1.194","article-title":"The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis","volume":"98","author":"Straus","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/13.S1.44_bb0055","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1200\/JCO.2000.18.12.2435","article-title":"Second cancers among long-term survivors of Hodgkin\u2019s disease diagnosed in childhood and adolescence","volume":"18","author":"Metayer","year":"2000","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"10.1093\/annonc\/13.S1.44_bb0060","first-page":"83","article-title":"Non-Hodgkin\u2019s lymphoma arising in patients treated for Hodg-kin\u2019s disease in the BNLI: a 20-year experience","volume":"2","author":"Bennett","year":"1991","journal-title":"British National Lymphoma Investigation. Ann Oncol"},{"key":"10.1093\/annonc\/13.S1.44_bb0065","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1200\/JCO.2001.19.7.2026","article-title":"Non-Hodgkin\u2019s lymphoma after primary Hodgkin\u2019s disease in the German Hodgkin\u2019s Lymphoma Study Group: incidence, treatment, and prognosis","volume":"19","author":"Rueffer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/13.S1.44_bb0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2000.18.3.487","article-title":"Long-term risk of second malignancy in survivors of Hodgkin\u2019s disease treated during adolescence or young adulthood","volume":"18","author":"van Leeuwen","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/13.S1.44_bb0075","first-page":"15","article-title":"T-cell rich B-cell non-Hodgkin\u2019s lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin\u2019s disease","volume":"28","author":"De Jong","year":"1996","journal-title":"Histo-pathology"},{"key":"10.1093\/annonc\/13.S1.44_bb0080","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1023\/A:1008485722472","article-title":"Elderly patients with non-Hodgkin\u2019s lymphoma: population-based results in The Netherlands","volume":"9","author":"Maartense","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/13.S1.44_bb0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00000478-199602000-00008","article-title":"T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin\u2019s disease","volume":"20","author":"McBride","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/13.S1.44_bb0090","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0002-9440(10)63027-1","article-title":"The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin\u2019s disease","volume":"159","author":"Torlakovic","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/13.S1.44_bb0095","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood.V97.6.1845","article-title":"Lymphocyte predominance Hodgkin\u2019s disease is characterized by recurrent genomic imbalances","volume":"97","author":"Franke","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/13.S1.44_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2559.2002.01291.x","article-title":"T cell\/histiocyte rich large B cell lymphoma: a distinct diffuse large B cell lymphoma subtype showing characteristic morphologic and immuno-phenotypic features","volume":"40","author":"Achten","year":"2002","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/13.S1.44_bb0105","first-page":"1269","article-title":"T cell\/histiocyte rich large B cell lymphoma","volume":"20","author":"Achten","year":"2002","journal-title":"A distinct clinicopathological entity. J Clin Oncol"},{"key":"10.1093\/annonc\/13.S1.44_bb0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00000478-200103000-00003","article-title":"Pathologic and clinical features of 77 Hodgkin\u2019s lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study","volume":"25","author":"Cazals-Hatem","year":"2001","journal-title":"Am J Surg Pathol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420312291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420312291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/13\/suppl_1\/44\/524796\/mdf608.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:37:48Z","timestamp":1582184268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420312291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":23,"alternative-id":["S0923753420312291"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/13.s1.44","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}